[gov_bean_ counter]

Mossad got the genetic code from China…
TFH off.

[ButThreeLeftsDo]

Sounds expensive.

[Titus-Maximus]

Using the body’s own stem cells. Cannot be patented so Fauci is not interested.

[Responsibility2nd]

This drug will never get anywhere here in the US. Big Pharma, Big media and Big Gov would rather push vaccines.

[gas_dr]

One would think this would be heralded as wonderful yet the naysayers apparently want it to be free, never miss a chance to attack the opposite side and continually throw insane water on a true breakthrough that has ramification for multiple disease states.

Seems like we have our very own free republic commies especially with the expensive statement. Surely the next comment is that ivermectin is cheap. However it is not efficacious in disease. Particularly advanced disease. This is another very promising breakthrough

I believed since the beginning we are about to see a golden age of targeted therapeutic and vaccination technology. It will be a golden age of virology if you will. It will be the one good thing to come out of this.

[Tennessee Nana]

Falsi has a seizer...

[ProtectOurFreedom]

Fascinating stuff. Thanks for posting. I added to my list of COVID treatments.

From the Bonus web description:

The therapeutic potential of mesenchymal stromal cells (MSCs) in the treatment of COVID-19 respiratory symptoms is attributed to the ability of MSCs to attenuate the hyper-inflammatory response – the cytokine storm triggered by the virus and the ensuing life-threatening acute respiratory distress syndrome (ARDS). MSC-mediated attenuation of the cytokine storm is achieved by modulating the proliferation and activation of immune cells through the secretion of immunosuppressive factors

MSCs are immune-evasive and intravenously administered. Allogeneic MSCs were demonstrated to be safe and do not elicit an immune response. Pre-clinical studies have demonstrated that following intravenous administration, the MSCs predominantly accumulate in the injured lung. By producing keratinocyte, endothelial, and hepatocyte growth factors, MSCs promote the regeneration of lung epithelial cells, prevent the apoptosis of endothelial cells, and contribute to the repair of the alveolar-epithelial barrier damaged by the cytokine storm.

In addition, systemically administered MSCs can also help other organs that are infected by the virus, such as the heart, liver, kidney and digestive organs, and possibly save patients from acute myocardial injury, arrhythmia, acute kidney injury, shock, and death from multiple organ failure

Numerous pre-clinical animal studies have demonstrated the safety and efficacy of intravenous administered MSCs in the treatment of acute lung injury and acute respiratory distress.

I have not heard of mesenchymal stromal cells previously. This paper has a good description:

Mesenchymal stromal cells by Maria Ester Bernardo, Franco Locatelli, and Willem E Fibbe, 2009.

ABSTRACT
Mesenchymal stromal cells (MSCs) are multipotent cells that can be isolated from several human tissues and expanded ex vivo for clinical use. MSCs are identified by their adherent properties, immunephenotype, and differentiation potential. MSCs display immunological properties that have been demonstrated both in vitro and in vivo, in animal models and in humans, although the exact mechanisms underlying these effects remain largely unknown. MSCs preferentially home to damaged tissue and secrete paracrine factors with anti-inflammatory properties. The immunomodulatory and reparative and anti-inflammatory properties of MSCs have been tested in a variety of animal models and have been applied in specific clinical settings. Potential clinical applications of MSCs include prevention and treatment of therapy-resistant acute graft-versus-host disease, prevention and treatment of rejection after either hematopoieitc stem cell and solid organ transplantation, tissue repair, and treatment of inborn errors and autoimmune diseases.

This review focuses on recent advances that have broadened our understanding of the biological and functional properties of MSCs, which are increasingly attracting the attention of researchers involved in the optimization of approaches for reparative and regenerative cell therapy, as well as in the perspective of modulating immune response against alloantigens or, even, autoantigens.

[LesbianThespianGymnasticMidget]

They get it from fatty tissue? Liposuction to save lives. The truth is stranger than fiction.

[proxy_user]

I’m not surprised they announced it at the stock exchange. If it really works this well, the patents are like a license to print money.

[NonValueAdded]

So, like, we can donate our fat to make the drug? Kewl!